News

Mymetics Reports Successful Preclinical Study Results with Cop-Virosomes as Second-Generation Allergy Immunotherapy

Mymetics Corporation announced that Stallergenes Greer and Anergis, reported the results of a joint research study evaluating the effects of the second generation Contiguous Overlapping Peptides (COP) allergen immunotherapy in a therapeutic model of birch allergy, with the aim of shortening the AIT administration schemes.
Mymetics Reports Successful Preclinical Study Results with Cop-Virosomes as Second-Generation Allergy Immunotherapy

GSK Announces Intention to Produce 1 Billion doses of Pandemic Vaccine Adjuvant in 2021

GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted COVID-19 vaccine candidates.
GSK Announces Intention to Produce 1 Billion doses of Pandemic Vaccine Adjuvant in 2021

Core Life Analytics Closes €1M Series A Deal

The Netherlands-based data analytics company, Core Life Analytics, has closed a €1m Series A financing round. The investor team is composed of BOM Brabant Ventures, Utrecht Holdings and TechFund One.
Core Life Analytics Closes €1M Series A Deal

LUMC Constructs the Largest Stem Cell Facility for The Netherlands and Beyond

Leiden University Medical Center (LUMC) will start this year with the construction of the largest non-profit stem cell and gene therapy facility in the Netherlands, and one of the largest facilities in Europe. In the ‘NECSTGEN’ facility, the Netherlands Centre for the Clinical advancement of Stem Cell and Gene Therapies, research will be conducted in the field of regenerative medicine.
LUMC Constructs the Largest Stem Cell Facility for The Netherlands and Beyond

Organon Returns to The Netherlands

De bedrijfsnaam Organon keert terug in Nederland. Dat is het resultaat van overleg tussen de MSD-directie in Nederland en de Landelijke Ondernemingsraad die hierover advies moest uitbrengen. Vanuit de ondernemingsraad is er groen licht voor uitvoering en vervolgstappen in Nederland.
Organon Returns to The Netherlands

BOM Invests in Haermonics for Better Care After Open Heart Surgery

Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties.
BOM Invests in Haermonics for Better Care After Open Heart Surgery

WHO Summit Confirms Global Approach COVID-19

Op de jaarvergadering van de Wereldgezondheidsorganisatie WHO hebben meer dan 130 landen een resolutie aangenomen om gezamenlijk de wereldwijde coronapandemie te bestrijden.
WHO Summit Confirms Global Approach COVID-19

The CE Tool as a Convenient Check for the MDR

Door de COVID-19 pandemie is de introductie van de nieuwe wetgeving voor medische hulpmiddelen in Europa, de Medical Device Regulation (MDR), een jaar uitgesteld. Hierdoor heeft u een jaar langer de tijd om uw certificering van uw product of software op orde te krijgen. U kunt deze tijd gebruiken om u goed voor te bereiden en te laten adviseren waar dat nodig is.
The CE Tool as a Convenient Check for the MDR

News article 4

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur congue mollis risus, imperdiet mollis velit convallis eu. Cras dui lorem, scelerisque at felis quis, convallis sodales ante.
News article 4

First Clinical Trial with Genetically Modified Malaria Vaccine Completed

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.
First Clinical Trial with Genetically Modified Malaria Vaccine Completed